rs26279
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002439.5(MSH3):c.3133G>A(p.Ala1045Thr) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.717 in 1,610,178 control chromosomes in the GnomAD database, including 415,407 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002439.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH3 | NM_002439.5 | c.3133G>A | p.Ala1045Thr | missense_variant, splice_region_variant | 23/24 | ENST00000265081.7 | NP_002430.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081.7 | c.3133G>A | p.Ala1045Thr | missense_variant, splice_region_variant | 23/24 | 1 | NM_002439.5 | ENSP00000265081 | P2 |
Frequencies
GnomAD3 genomes AF: 0.706 AC: 107286AN: 151968Hom.: 37881 Cov.: 32
GnomAD3 exomes AF: 0.729 AC: 183208AN: 251172Hom.: 67007 AF XY: 0.730 AC XY: 99085AN XY: 135756
GnomAD4 exome AF: 0.719 AC: 1047769AN: 1458094Hom.: 377500 Cov.: 38 AF XY: 0.720 AC XY: 522185AN XY: 725564
GnomAD4 genome AF: 0.706 AC: 107363AN: 152084Hom.: 37907 Cov.: 32 AF XY: 0.707 AC XY: 52586AN XY: 74342
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 30, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2018 | This variant is associated with the following publications: (PMID: 25966119, 17205513, 20708344) - |
Hereditary cancer-predisposing syndrome Benign:2
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Feb 27, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at